Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CHFS

Nuwellis (CHFS) Stock Price, News & Analysis

Nuwellis logo

About Nuwellis Stock (NASDAQ:CHFS)

Advanced Chart

Key Stats

Today's Range
$5.12
$5.48
50-Day Range
$3.53
$6.02
52-Week Range
$4.86
$37.50
Volume
254,904 shs
Average Volume
467,323 shs
Market Capitalization
$31.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CHFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuwellis and its competitors with MarketBeat's FREE daily newsletter.

CHFS Stock News Headlines

Nuwellis Gains FDA Clearance for New Catheter
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel
Nuwellis Appoints John L. Erb as CEO
See More Headlines

CHFS Stock Analysis - Frequently Asked Questions

Nuwellis, Inc. (NASDAQ:CHFS) posted its quarterly earnings results on Monday, March, 1st. The company reported ($1.57) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.91) by $0.34. The company had revenue of $2.04 million for the quarter. Nuwellis had a negative net margin of 254.26% and a negative trailing twelve-month return on equity of 173.61%.

Shares of Nuwellis reverse split on the morning of Friday, October 13th 2017.The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuwellis investors own include Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Biocept (BIOC), VBI Vaccines (VBIV), Prima BioMed (IMMP), NightHawk Biosciences (NHWK) and Sorrento Therapeutics (SRNE).

Company Calendar

Last Earnings
3/01/2021
Today
8/22/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:CHFS
Previous Symbol
NASDAQ:SSH
CIK
1506492
Fax
N/A
Employees
66
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($279.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$18.11 million
Net Margins
-254.26%
Pretax Margin
N/A
Return on Equity
-173.61%
Return on Assets
-131.01%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.87
Quick Ratio
5.97

Sales & Book Value

Annual Sales
$5.51 million
Price / Sales
5.80
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.79 per share
Price / Book
0.41

Miscellaneous

Outstanding Shares
6,037,000
Free Float
N/A
Market Cap
$31.94 million
Optionable
Not Optionable
Beta
1.55
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:CHFS) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners